ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 753664 Null 0.0137891122538509 0.21127599
NSC 759878 Irinotecan hydrochloride (USAN) 0.0137891122538509 0.78143834
NSC 105014 Cladribine 0.013789112253851 0.48108287
NSC 132313 Dianhydrogalactitol 0.013789112253851 0.87607554
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.013789112253851 0.4313663
NSC 154948 M-AMSA 0.013789112253851 0.70897869
NSC 363143 Stannane, dichlorodiphenyl-, compd. with 1,4,7,10,13,16-hexaoxacyclooctadecane (1:1) 0.0171490505199911 0.12497917
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0171490505199911 0.32043364
NSC 613011 Latrunculin A 0.0171490505199911 0.10363879
NSC 634785 4-Piperidinone, 1-[3-(diethylamino)-1-oxopropyl]-3,5-bis- (phenylmethylene)-, monohydrochloride 0.0171490505199911 0.053946311
Total:99  Current:46    [First] [Prev] [Next] [Last]